lamotrigin actavis tablet 25mg - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

lamotrigine actavis lamotrigine 25mg tablet blister pack

cipla australia pty ltd - lamotrigine, quantity: 25 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; lactose monohydrate; magnesium stearate; microcrystalline cellulose; maize starch - lamotrigine actavis (lamotrigine) is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children over 12 years of age. there is extensive experience with lamotrigine used initially as add-on therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs. initial monotherapy treatment in newly diagnosed paediatric patients is not recommended. (see clinical trials.)

United States - English - NLM (National Library of Medicine)

lamotrigine tablet, film coated, extended release

actavis pharma, inc. - lamotrigine (unii: u3h27498ks) (lamotrigine - unii:u3h27498ks) - lamotrigine 25 mg - lamotrigine extended-release tablets are indicated as adjunctive therapy for primary generalized tonic-clonic (pgtc) seizures and partial-onset seizures with or without secondary generalization in patients aged 13 years and older. lamotrigine extended-release tablets are indicated for conversion to monotherapy in patients aged 13 years and older with partial-onset seizures who are receiving treatment with a single antiepileptic drug (aed). safety and effectiveness of lamotrigine extended-release tablets have not been established (1) as initial monotherapy or (2) for simultaneous conversion to monotherapy from 2 or more concomitant aeds. safety and effectiveness of lamotrigine extended-release tablets for use in patients younger than 13 years have not been established. lamotrigine extended-release tablets are contraindicated in patients who have demonstrated hypersensitivity (e.g., rash, angioedema, acute urticaria, extensive pruritus, mucosal ulceration) to the drug or its ingredients [see boxed warning, warn

Australia - English - Department of Health (Therapeutic Goods Administration)

lamotrigine actavis lamotrigine 200mg tablet blister pack

cipla australia pty ltd - lamotrigine, quantity: 200 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; sodium starch glycollate; maize starch; lactose monohydrate - lamotrigine actavis (lamotrigine) is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children over 12 years of age. there is extensive experience with lamotrigine used initially as add-on therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs. initial monotherapy treatment in newly diagnosed paediatric patients is not recommended. (see clinical trials.)

Australia - English - Department of Health (Therapeutic Goods Administration)

lamotrigine actavis lamotrigine 100mg tablet blister pack

cipla australia pty ltd - lamotrigine, quantity: 100 mg - tablet, uncoated - excipient ingredients: magnesium stearate; sodium starch glycollate; maize starch; lactose monohydrate; microcrystalline cellulose - lamotrigine actavis (lamotrigine) is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children over 12 years of age. there is extensive experience with lamotrigine used initially as add-on therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs. initial monotherapy treatment in newly diagnosed paediatric patients is not recommended. (see clinical trials.)

Australia - English - Department of Health (Therapeutic Goods Administration)

lamotrigine actavis lamotrigine 50mg tablet blister pack

cipla australia pty ltd - lamotrigine, quantity: 50 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; microcrystalline cellulose; lactose monohydrate; maize starch; magnesium stearate - lamotrigine actavis (lamotrigine) is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children over 12 years of age. there is extensive experience with lamotrigine used initially as add-on therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs. initial monotherapy treatment in newly diagnosed paediatric patients is not recommended. (see clinical trials.)